Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-02-12

Clinical Trial Update: Cholinergic Mechanisms of Gait Dysfunction in Parkinson's Disease Experiments 1 & 2 - Proj #3 [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update studying cholinergic mechanisms of gait dysfunction in Parkinson's disease; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Michigan | Conditions: Parkinson's Disease | Phase 2 | Status: COMPLETED | Results posted: 2021-02-12